| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/23/2003 | WO2003006042A1 Peptide for regulation of tissue plasminogen activator |
| 01/23/2003 | WO2003006034A2 Herbal formulation |
| 01/23/2003 | WO2003006026A1 Combinations for the treatment of inflammatory disorders |
| 01/23/2003 | WO2003006017A2 Use of certain castanospermine esters in the treatment of influenza virus infections |
| 01/23/2003 | WO2003006010A1 Aerosol formulations of δ8 tetrahydrocannabinol |
| 01/23/2003 | WO2003006002A1 Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases |
| 01/23/2003 | WO2003005996A1 Programmable controlled release injectable opioid formulation |
| 01/23/2003 | WO2003005995A1 Core formulation comprising pioglitazone hydrochloride and a biguanide |
| 01/23/2003 | WO2003005994A1 Core formulation comprising troglitazone and a biguanide |
| 01/23/2003 | WO2003005993A1 Core formulation comprising troglitazone and a biguanide |
| 01/23/2003 | WO2003005992A1 Lyophilizing composition of drug-encapsulating polymer micelle and method for preparation thereof |
| 01/23/2003 | WO2003005991A1 A core formulation |
| 01/23/2003 | WO2003005989A2 Granulates containing liposoluble substances and a process for the preparation thereof |
| 01/23/2003 | WO2003005978A1 Remedy against skin diseases |
| 01/23/2003 | WO2003005968A2 Dual release levodopa ethyl ester and decarboxylase inhibitor with immediate release levodopa |
| 01/23/2003 | WO2003005967A2 Dual release levodopa ethyl ester and decarboxylase in controlled release core |
| 01/23/2003 | WO2003005961A2 A controlled release biodegradable gel matrix |
| 01/23/2003 | WO2003005959A2 Amphiphilic star-like macromolecules for drug delivery |
| 01/23/2003 | WO2003005952A2 Compositions and methods for delivery of proteins and adjuvants encapsulated in microspheres |
| 01/23/2003 | WO2003005951A2 Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery |
| 01/23/2003 | WO2003005950A2 Pharmaceutical dispensing apparatus and method |
| 01/23/2003 | WO2003005944A1 Sequential drug delivery systems |
| 01/23/2003 | WO2003005941A2 Insert for the treatment of dry eye |
| 01/23/2003 | WO2003005839A2 Edibles containing edible optical elements and methods |
| 01/23/2003 | WO2002083159B1 Palliative effects of morinda citrifolia oil and juice |
| 01/23/2003 | WO2002059184A3 Molecular imprinting of small particles, and production of small particles from solid state reactants |
| 01/23/2003 | WO2002053535A3 Process for making amlodipine, derivatives thereof, and precursors therefor |
| 01/23/2003 | WO2002049617A3 Self forming, thermodynamically stable liposomes and their applications |
| 01/23/2003 | WO2002049614A3 Intraocular irrigating solution having improved flow characteristics |
| 01/23/2003 | WO2002047731A3 Drug delivery compositions and coated medical devices |
| 01/23/2003 | WO2002045773A3 Use of electrolytes (ions in solution) to suppress charging of inhalation aerosols |
| 01/23/2003 | WO2002044232A3 Polyanhydrides |
| 01/23/2003 | WO2002043694A3 Edible pga(propylene glycol alginate) coating composition |
| 01/23/2003 | WO2002038183A3 Delivery devices |
| 01/23/2003 | WO2002038133A3 Compositions containing hydrolytically unstable compounds |
| 01/23/2003 | WO2002036767A3 Therapeutic oligonucleotides of reduced toxicity |
| 01/23/2003 | WO2002036127A3 Methods and compositions for the treatment of polycystic ovary syndrome with chromium complexes |
| 01/23/2003 | WO2002036096A3 Non-aspirating transitional viscoelastics for use in surgery |
| 01/23/2003 | WO2002026208A3 Emulsion vehicle for poorly soluble drugs |
| 01/23/2003 | WO2002024157A3 Acryl adhesive useful in transdermal drug delivery systems |
| 01/23/2003 | WO2002020619A3 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
| 01/23/2003 | WO2002017920A3 Use of methylphenidate compounds to enhance memory |
| 01/23/2003 | WO2002002607A3 Acid-modified arabinogalactan protein composition |
| 01/23/2003 | US20030018382 Process for improving vision |
| 01/23/2003 | US20030018222 Sovent extracting the dried marigold flower petals, eluting through an anion exchange resin column, diluting the eluent, crystallization; protecting lutein against deterioration, store for long time |
| 01/23/2003 | US20030018083 Methods of treating and preventing pain, anxiety, and incontinence using derivatives of (-)-venlafaxine |
| 01/23/2003 | US20030018074 Antiinflammatory agents; skin disorders; topical applying |
| 01/23/2003 | US20030018072 Utilization of dialkylfumarates |
| 01/23/2003 | US20030018069 Administering an aliphatic acid compound |
| 01/23/2003 | US20030018063 Physiologically active agents containing vicinal dithioglycols and use thereof in various branches of economy |
| 01/23/2003 | US20030018044 Treatment of ocular disease |
| 01/23/2003 | US20030018000 Process for producing wet ribavirin pellets |
| 01/23/2003 | US20030017994 Reducing dosage |
| 01/23/2003 | US20030017972 Drug delivery |
| 01/23/2003 | US20030017964 Administration of agents via the PEPT-2 transporter |
| 01/23/2003 | US20030017617 Mammalian receptor proteins; related reagents and methods |
| 01/23/2003 | US20030017564 Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiogenesis |
| 01/23/2003 | US20030017214 Solid microbiocides of zinc chloride and cefuroxime axetil |
| 01/23/2003 | US20030017211 Method for drug delivery to the pulmonary system |
| 01/23/2003 | US20030017210 Controlled-release for oral administration of cisplatin |
| 01/23/2003 | US20030017209 Breath protection microcapsules |
| 01/23/2003 | US20030017208 Electrospun pharmaceutical compositions |
| 01/23/2003 | US20030017207 Compositions and methods for treating vulvovaginitis and vaginosis |
| 01/23/2003 | US20030017206 Negatively charged amphiphilic block copolymer as drug carrier |
| 01/23/2003 | US20030017205 Nutritional tablet of caplet with a coating of a film forming polymer and folic acid; rapid release |
| 01/23/2003 | US20030017204 Microcrystalline cellulose and carrageenan and a strengthening polymer and/or a plasticizer |
| 01/23/2003 | US20030017203 Lamination with a first layer of a pH-lowering agent and a second layer of a peptide, an absorption enhancer to promote bioavailability and enteric coating |
| 01/23/2003 | US20030017202 Brittle-coating, soft core dosage form |
| 01/23/2003 | US20030017201 Pharmaceutical composition comprising entracapone, levodopa, and carbidopa |
| 01/23/2003 | US20030017200 Oral administration of terbinafine, a buffering component and a disintegrant; fungicides |
| 01/23/2003 | US20030017198 Process for the preparation of direct tabletting formulations and aids |
| 01/23/2003 | US20030017197 Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells |
| 01/23/2003 | US20030017196 Oligonucleotide inhibitors of bcl-xL |
| 01/23/2003 | US20030017195 Mucoadhesive patch system for drug delivery comprising an impermeable backing layer, a drug reservoir and a mucoadhesive layer; enhancing bioavailabilities of poorly absorbed drugs such as polar molecules or bioactive peptides |
| 01/23/2003 | US20030017189 Gastric retaining oral liquid dosage form |
| 01/23/2003 | US20030017184 Emulsifier-free finely dispersed systems of the oil-in-water type |
| 01/23/2003 | US20030017183 Dermatological suspensions(micro-matrix) |
| 01/23/2003 | US20030017181 Including one or more anesthetic agents and/or one or more anti-inflammatory agents and/or a combination of ammonium, sodium, and potassium salts, preferably of an alpha-hydroxy acid |
| 01/23/2003 | US20030017176 Preparations of the W/O emulsion type with an increased water content, comprising moderately polar lipids and silicone emulsifiers and, if desired, cationic polymers |
| 01/23/2003 | US20030017175 Sublingual administration of dihydroergotamine for the treatment of migraine |
| 01/23/2003 | US20030017169 Controlled release systems for polymers |
| 01/23/2003 | US20030017133 Composition comprising a medicament and a film forming vehicle comprising polymethacrylate, and an adhesive that sticks to mucous membranes. |
| 01/23/2003 | US20030017121 Use of electrolytes (ions in solution) to suppress charging of inhalation aerosols |
| 01/23/2003 | US20030017120 Delivery of erectile dysfunction drugs through an inhalation route |
| 01/23/2003 | US20030017119 Aerosol comprises particles comprising at least 10 percent by weight of an opioid, and wherein the opioid is not heroin; opiods include morphine, codeine, naltrexone, buprenorphine, fentanyl, nalbuphine, naloxone, etc. |
| 01/23/2003 | US20030017118 An aerosol for inhalation therapy, wherein the aerosol comprises particles comprising at least 10 percent by weight of an antipsychotic such as olanzapine, trifluoperazine, haloperidol, loxapine, clozapine, quetiapine, promazine, etc. |
| 01/23/2003 | US20030017117 Delivery of analgesics through an inhalation route |
| 01/23/2003 | US20030017116 Delivery of sedative-hypnotics through an inhalation route |
| 01/23/2003 | US20030017115 Aerosol comprises particles comprising at least 10 percent by weight of a drug ester. |
| 01/23/2003 | US20030017114 Aerosol comprises particles of chlordiazepoxide, betahistine, clonidine, testosterone, conjugated estrogens, estrogen esters, estradiol, estradiol esters, ethinyl estradiol, ethinyl estradiol esters, or hyoscyamine. |
| 01/23/2003 | US20030017113 Spray dried particles having specified aerodynamic characteristics are produced by atomizing a liquid feed and contacting the liquid feed with a drying gas, such as, for example, air or nitrogen. |
| 01/23/2003 | US20030017109 Mixable combination for generating a suspension of stable microbubbles for ultrasonic imaging |
| 01/23/2003 | US20030015814 Device and method for producing solid shape containing an active ingredient |
| 01/23/2003 | US20030015197 Method of forming an aerosol for inhalation delivery |
| 01/23/2003 | US20030015196 Aerosol forming device for use in inhalation therapy |
| 01/23/2003 | US20030015194 Process and apparatus for producing inhalable medicaments |
| 01/23/2003 | US20030015190 Delivery of compounds for the treatment of migraine through an inhalation route |
| 01/23/2003 | US20030015189 Delivery of antihistamines through an inhalation route |
| 01/23/2003 | CA2777199A1 Methods and materials for the treatment of testosterone deficiency in men |
| 01/23/2003 | CA2454106A1 Mixed complexes for masking the taste of bitter active substances |